Comprehensive Analysis of Pertinent Genes and Pathways in Atrial Fibrillation

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2022 Jan 10

PMID 35003319

Authors

Yanzhe Wang

Wenjuan Cai

Liya Gu

Xuefeng Ji

Qiusheng Shen

Affiliations

Soon will be listed here.

Abstract

Purpose: Atrial fibrillation (AF) is the most frequent arrhythmia in clinical practice. The pathogenesis of AF is not yet clear. Therefore, exploring the molecular information of AF displays much importance for AF therapy.

Methods: The GSE2240 data were acquired from the Gene Expression Omnibus (GEO) database. The R limma software package was used to screen DEGs. Based on the Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) databases, we conducted the functions and pathway enrichment analyses. Then, the STRING and Cytoscape software were employed to build Protein-Protein Interaction (PPI) network and screen for hub genes. Finally, we used the Cell Counting Kit-8 (CCK-8) experiment to explore the effect of hub gene knockdown on the proliferation of AF cells.

Result: 906 differentially expressed genes (DEGs), including 542 significantly upregulated genes and 364 significantly downregulated genes, were screened in AF. The genes of AF were mainly enriched in vascular endothelial growth factor-activated receptor activity, alanine, regulation of histone deacetylase activity, and HCM. The PPI network constructed of significantly upregulated DEGs contained 404 nodes and 514 edges. Five hub genes, ASPM, DTL, STAT3, ANLN, and CDCA5, were identified through the PPI network. The PPI network constructed by significantly downregulated genes contained 327 nodes and 301 edges. Four hub genes, CDC42, CREB1, AR, and SP1, were identified through this PPI network. The results of CCK-8 experiments proved that knocking down the expression of CDCA5 gene could inhibit the proliferation of H9C2 cells.

Conclusion: Bioinformatics analyses revealed the hub genes and key pathways of AF. These genes and pathways provide information for studying the pathogenesis, treatment, and prognosis of AF and have the potential to become biomarkers in AF treatment.

Citing Articles

Decreased METTL3 in atrial myocytes promotes atrial fibrillation.

Shi J, Zhu X, Yu R, Liu W, Yang J, Tang L Europace. 2025; 27(2).

PMID: 39991872 PMC: 11848519. DOI: 10.1093/europace/euaf021.

Identification of senescence-related genes for potential therapeutic biomarkers of atrial fibrillation by bioinformatics, human histological validation, and molecular docking.

Liu J, Zhou T, Bao Y, Lin C, Chen Q, Dai Y Heliyon. 2024; 10(19):e37366.

PMID: 39381104 PMC: 11456832. DOI: 10.1016/j.heliyon.2024.e37366.

Establishment of Risk Model and Analysis of Immunoinfiltration Based on Mitophagy-Related Associated Genes in Atrial Fibrillation.

Sang W, Wang L, Yan X, Sun H, Han Y, Wang F J Inflamm Res. 2023; 16:2561-2583.

PMID: 37346800 PMC: 10281282. DOI: 10.2147/JIR.S415410.

Mathematical Modeling and Computational Prediction of High-Risk Types of Human Papillomaviruses.

Zhang J, Wang K Comput Math Methods Med. 2022; 2022:1515810.

PMID: 35912141 PMC: 9334084. DOI: 10.1155/2022/1515810.

References

Mezache L, Struckman H, Greer-Short A, Baine S, Gyorke S, Radwanski P . Vascular endothelial growth factor promotes atrial arrhythmias by inducing acute intercalated disk remodeling. Sci Rep. 2020; 10(1):20463. PMC: 7687901. DOI: 10.1038/s41598-020-77562-5. View

Hack C . Integrated transcriptome and proteome data: the challenges ahead. Brief Funct Genomic Proteomic. 2005; 3(3):212-9. DOI: 10.1093/bfgp/3.3.212. View

Kamath S, Chin B, Blann A, Lip G . A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation. Blood Coagul Fibrinolysis. 2002; 13(7):627-36. DOI: 10.1097/00001721-200210000-00008. View

Chatap G, Giraud K, Vincent J . Atrial fibrillation in the elderly: facts and management. Drugs Aging. 2002; 19(11):819-46. DOI: 10.2165/00002512-200219110-00002. View

. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2014; 43(Database issue):D1049-56. PMC: 4383973. DOI: 10.1093/nar/gku1179. View

Barrett T, Troup D, Wilhite S, Ledoux P, Evangelista C, Kim I . NCBI GEO: archive for functional genomics data sets--10 years on. Nucleic Acids Res. 2010; 39(Database issue):D1005-10. PMC: 3013736. DOI: 10.1093/nar/gkq1184. View

Andrews M, Nelson B . Atrial fibrillation. Mt Sinai J Med. 2006; 73(1):482-92. View

Alberti S, Hyman A . Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat Rev Mol Cell Biol. 2021; 22(3):196-213. DOI: 10.1038/s41580-020-00326-6. View

Xu H, Wang J, Yuan J, Hu F, Yang W, Guo C . Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2020; 9(8):e015013. PMC: 7428529. DOI: 10.1161/JAHA.119.015013. View

10.

Kato K, Oguri M, Hibino T, Yajima K, Matsuo H, Segawa T . Genetic factors for lone atrial fibrillation. Int J Mol Med. 2007; 19(6):933-9. View

11.

Du J, Yuan Z, Ma Z, Song J, Xie X, Chen Y . KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model. Mol Biosyst. 2014; 10(9):2441-7. DOI: 10.1039/c4mb00287c. View

12.

Burke H . Discovering patterns in microarray data. Mol Diagn. 2001; 5(4):349-57. DOI: 10.1007/BF03262096. View

13.

Chimenti C, Russo M, Carpi A, Frustaci A . Histological substrate of human atrial fibrillation. Biomed Pharmacother. 2009; 64(3):177-83. DOI: 10.1016/j.biopha.2009.09.017. View

14.

Gul A, Hassan M, Mahmood S, Chen W, Rahmani S, Naseer M . Genetic studies of autosomal recessive primary microcephaly in 33 Pakistani families: Novel sequence variants in ASPM gene. Neurogenetics. 2006; 7(2):105-10. DOI: 10.1007/s10048-006-0042-4. View

15.

Hart R, Sherman D, Easton J, Cairns J . Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology. 1998; 51(3):674-81. DOI: 10.1212/wnl.51.3.674. View

16.

Szczepanek K, Chen Q, Derecka M, Salloum F, Zhang Q, Szelag M . Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem. 2011; 286(34):29610-20. PMC: 3191002. DOI: 10.1074/jbc.M111.226209. View

17.

van Driel M, Brunner H . Bioinformatics methods for identifying candidate disease genes. Hum Genomics. 2006; 2(6):429-32. PMC: 3525160. DOI: 10.1186/1479-7364-2-6-429. View

18.

Chen-Plotkin A, Sadri-Vakili G, Yohrling G, Braveman M, Benn C, Glajch K . Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Dis. 2006; 22(2):233-41. DOI: 10.1016/j.nbd.2005.11.001. View

19.

Lugero C, Kibirige D, Kayima J, Mondo C, Freers J . Atrial fibrillation among the black population in a Ugandan tertiary hospital. Int J Gen Med. 2016; 9:191-8. PMC: 4908944. DOI: 10.2147/IJGM.S100637. View

20.

Gomes M, Pagan L, Okoshi M . Non-Pharmacological Treatment of Cardiovascular Disease | Importance of Physical Exercise. Arq Bras Cardiol. 2019; 113(1):9-10. PMC: 6684172. DOI: 10.5935/abc.20190118. View